|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Total Revenue, net | |||||
| Costs and Expenses: | |||||
| Cost of goods sold | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Intangible asset amortization | |||||
| Goodwill impairment charge | |||||
| Total costs and expenses | |||||
| Operating (loss) income | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain from sale of businesses | |||||
| Other (expense) income, net | |||||
| (Loss) income before income taxes | |||||
| (Benefit) provision for income taxes | |||||
| Net (loss) income | |||||
| Net (loss) income per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding (Note 13. Net Income Per Share): | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...